TheEdgeResearch
Home / Stocks / MDCX

Medicus Pharma Ltd. Common Stock (MDCX)

NASDAQ Healthcare Biotechnology
$0.33 ▼ -10.78%
Market Cap
$7.3M
Sector
Healthcare
Industry
Biotechnology
Beta
-0.65
52-Wk Range
0.25-3.05
CEO
Raza Bokhari
Country
CA
Currency
USD

Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.

Open full interactive analysis & DCF →